Related by context. All words. (Click for frequent words.) 70 Initiates Clinical Trial 69 Hematologic Oncology 69 Initiates Clinical 69 Prolongs Survival 69 Autoimmune Disease 69 Renal Cancer 68 Metabolic Disease 68 Acute Heart Failure 68 See CLINICAL PHARMACOLOGY 68 Investigational Treatment 68 Autoimmune Diseases 67 Patient Outcomes 67 Demonstrates Sustained 67 Pulmonary Arterial Hypertension 67 Hypercholesterolemia 67 Inflammatory Disease 67 Clinical Evaluation 67 Clinical Practice Guidelines 67 Gets FDA Clearance 67 Advanced Melanoma 67 Respiratory Virus 67 FDA Approvals 67 Myelodysplastic Syndromes 67 Asthma COPD 67 Minimally Invasive Treatment 67 Cardiotoxicity 67 Acute Ischemic Stroke 66 Systemic Sclerosis 66 Anti Infective 66 RNAi Therapeutic 66 Lymphoid 66 Venous Thromboembolism 66 Investigational Compound 66 Insulin Delivery 66 Initiate Clinical Trial 66 Improves Outcomes 66 Inflammatory Diseases 66 Phase IIb Clinical Trial 66 Lung Injury 66 Severe Asthma 66 Heart Transplant Recipients 66 Cardiac Rhythm 66 Cancer Stem Cells 66 Phase Ib Clinical Trial 66 HCV Protease Inhibitor 66 Fungal Infections 66 Laryngeal Cancer 65 Rheumatoid Arthritis Patients 65 Chronic Heart Failure 65 Immune Mediated 65 Clinical Outcomes 65 Vertebral Fractures 65 Metabolic Disorder 65 Clinical Outcome 65 Reduces Mortality 65 Meets Primary Endpoint 65 Patient Enrollment 65 Multiple Myeloma Patients 65 Initiates Phase III 65 Schizophrenia Treatment 65 Hematological Malignancies 65 Phase 2b Clinical Trial 65 Oral Mucositis 65 Urology Gynecology 65 Receives Orphan Drug Designation 65 Shows Promise Against 65 Investigational Drug 65 Novel Therapeutics 65 Vulnerable Plaque 65 Non Invasive Treatment 65 Metabolic Endocrinology 65 Suicidality 65 Novel Therapeutic 65 Differential Diagnosis 65 Sleep Disturbances 65 Therapeutic Antibody 65 Secondary Hyperparathyroidism 65 Interventional Procedures 65 Neoadjuvant Chemotherapy 65 Antiplatelet 65 Clostridium difficile Infection 65 Genetic Diseases 65 Inhaled Liposomal Ciprofloxacin 65 Neurodegenerative 65 Colorectal Cancer Screening 64 Initiates Enrollment 64 Renal Anemia 64 Carotid Stenting 64 Clinical Decision Making 64 Inflammatory Markers 64 Aneurysm Repair 64 Oral Fingolimod 64 Pregnancy Outcomes 64 Hernia Repair 64 Drug Shows Promise 64 Atopic Dermatitis 64 Clinical Trial Results 64 Prophylactic Treatment 64 JAK Inhibitor 64 Eye Diseases 64 Mouse Model 64 Patients Treated With 64 Renal Artery 64 IND Filing 64 Lupus Drug 64 Gastric Cancer 64 ARIXTRA R 64 Acute Decompensated Heart Failure 64 Prospective Randomized 64 Adverse Event 64 Urinary Incontinence 64 Cardiac Imaging 64 Treatment Resistant 64 Preclinical Data 64 Ischemic Stroke 64 ACE Inhibitors 64 Cell Transplant 64 Successfully Treated 64 Novel Therapies 64 Acute Coronary Syndromes 64 Critically Ill Patients 64 Receives Positive Opinion 64 Carotid Endarterectomy 64 Reperfusion Injury 64 Shows Efficacy 64 Protease Inhibitor 64 Castration Resistant Prostate Cancer 64 Prostate Disease 64 Bipolar Disorders 64 Risk Stratification 64 Proven Effective 64 Neurodegenerative Disease 64 Fibromyalgia Syndrome 64 Diabetic Foot Ulcer 64 Diagnostic Tests 64 Overactive Bladder 64 Novel Oral 64 Patients Suffering 64 Severe Sepsis 64 CNS Therapeutics 64 Peripheral Arterial 64 Psoriasis Drug 64 Metabolic Disorders 64 Diastolic Heart Failure 64 Hepatitis C Virus 64 Maven Semantic 64 Acute Pain 64 Drug Prevents 64 Sleep Disordered Breathing 64 Guidelines Issued 64 Antimicrobial Coating 64 Expanded Indication 64 Immunotherapeutic 64 #-# Full Text 64 Molecular Diagnostic 64 Submits NDA 64 Valvular 64 Clinical Trial Evaluating 63 Cognitive Impairment 63 Prostate Cancer Treatment 63 Patient Registry 63 Anticoagulation 63 Female Urology 63 Image Guided 63 Cardiovascular Outcomes 63 Emerging Therapies 63 Osteoporosis Treatment 63 Demonstrates Significant 63 Nanoemulsion 63 Dialysis Outcomes 63 Completes Patient Enrollment 63 Tyrosine Kinase Inhibitor 63 Clinical Trial Data 63 Phase 2a Clinical Trial 63 Hyperlipidemia 63 Presents Positive 63 Hepatocellular Carcinoma 63 Treating Chronic 63 Surgical Treatment 63 AFREZZA TM 63 Anticancer Drug 63 Cutaneous T 63 Heart Failure Patients 63 Protein Involved 63 Refractory Angina 63 Transdermal Delivery 63 Rheumatoid Arthritis Drug 63 Dyslipidemia 63 Metastatic Melanoma 63 Radiation Treatment 63 Tumor Response 63 Presents Preclinical Data 63 Valvular Heart Disease 63 Ventricular Arrhythmias 63 Post Operative 63 ST Segment Elevation 63 Warfarin Coumadin 63 Seasonal Influenza Vaccine 63 Gastrointestinal Disorders 63 Neuroprotection 63 Hospital Acquired Pneumonia 63 Fabry Disease 63 Guideline Update 63 Improves Survival 63 Medication Adherence 63 Combo Therapy 63 Present Preclinical Data 63 Ischemic 63 Shown Effective 63 Randomized Trials 63 Uterine Fibroids 63 Lung Cancer Trial 63 See WARNINGS 63 Clinical Guideline 63 Therapeutic Antibodies 63 Cognitive Problems 63 Chronic Sinusitis 63 ANN INTERN MED 63 Begins Clinical Trial 63 Combination Treatment 63 Nicotine Vaccine 63 Meta Analysis 63 Phase III Clinical Trial 63 Fracture Risk 63 RNAi Therapeutics 63 Generalized Anxiety Disorder 63 Protein Biomarker 63 Estrogen Receptor 63 Pivotal Trial 63 Biostatistical 63 Beta Blocker 63 Newly Diagnosed Multiple Myeloma 63 Genetic Testing 63 Diabetology 63 Thromboembolic 63 Diabetes Hypertension 63 Kidney Transplant Patients 63 Gastrointestinal Oncology 63 Vaccine Adjuvant 63 Files IND 63 Inflammatory Arthritis 63 ST Elevation Myocardial 63 Lowers Risk 63 Viral Infections 63 JAK2 Inhibitor 63 Eluting Stent 63 Biomarker Study 63 Cypher Sirolimus 63 Allergic Rhinitis 63 Relapsing Multiple Sclerosis 63 Renal Transplantation 63 Kidney Function 63 Prognostic Value 63 Cardiovascular Metabolic 63 Diabetic Neuropathy 62 Myocardial Ischemia 62 Progressive Multifocal Leukoencephalopathy 62 Phase 2a Trial 62 Treatment Outcome 62 Patients Receiving 62 Bone Metastases 62 Antitumor Activity 62 Juvenile Idiopathic Arthritis 62 Transdermal Patch 62 HER2 Positive 62 Slow Progression 62 Phase 2b Trial 62 Prospective Multicenter 62 Drug Formulation 62 Demonstrates Ability 62 Subgroup Analysis 62 Novel Antibiotic 62 Chronic Renal Failure 62 Antifungals 62 Surgical Procedures 62 Hepatitis C Treatment 62 Improve Diagnosis 62 Advanced Renal Cell 62 Septic Shock 62 Rhinosinusitis 62 Breast Tumor 62 Significantly Improved 62 Sustained Efficacy 62 Osteoarthritis Patients 62 Mechanical Circulatory Support 62 Analytical Tool 62 ALN HPN 62 Diabetic Patients 62 Circulatory Support 62 Tumor Microenvironment 62 Predict Risk 62 Dual Antiplatelet Therapy 62 Medication Errors 62 Afib 62 Lymphocytic 62 Peripheral Arterial Disease 62 Remote Patient Monitoring 62 Immunomedics Announces 62 Drug Candidate 62 Anti Tumor 62 Initiates Phase 2b 62 Personalized Genetic 62 orally inhaled migraine 62 Iron Overload 62 Growth Hormone Deficiency 62 Hematologic Malignancies 62 Clinical Practice Guideline 62 Novel Compound 62 Personalised Medicine 62 Granted Orphan Drug 62 Diabetic Macular Edema 62 Cancer Immunotherapy 62 Muscle Wasting 62 Antibody Drug Conjugate 62 Preclinical Models 62 CT Angiography 62 Bipolar Mania 62 Carotid Artery Stenting 62 Genitourinary 62 Diagnostic Criteria 62 Bipolar Depression 62 Intravenous Formulation 62 Respiratory Disorders 62 Solid Tumors 62 Left Ventricular 62 von Willebrand Disease 62 Successfully Treats 62 Chronic Myelogenous Leukemia 62 Detrol Detrol LA 62 Drug Fails 62 Acute Liver Failure 62 Improve Survival 62 Pivotal Clinical Trial 62 Stent Thrombosis 62 Tyrosine Kinase Inhibitors 62 Hospitalized Patients 62 Cancer Vaccines 62 Comorbidities 62 Hemodialysis Patients 62 Tumor Targeting 62 Anthracycline 62 Nesiritide 62 Investigational Agent 62 Patients Undergoing 62 Contrast Enhanced 62 Enlarged Prostate 62 Respiratory Infections 62 Kinase Inhibitors 62 Regenerative Cells 62 Interferon beta 1a 62 Musculo Skeletal Disorders 62 Hormone Receptor Positive 62 Asthma Treatment 62 Survival Benefit 62 Fondaparinux 62 Genetic Disorders 62 Inhaled Insulin 62 Receives Orphan Drug 62 Thromboembolism 62 Mouse Models 62 Ozarelix 62 Neurodegenerative Disorders 62 VIVUS Qnexa 62 Orphan Diseases 62 Initiates Clinical Trials 62 Receives Approvable Letter 62 Significantly Reduces 62 Bacteremia 62 Practice Patterns 62 Pelvic Pain 62 #:#-#,# CrossRef Medline [002] 62 Adjuvant Treatment 62 Completes Enrollment 62 Diagnosis Treatment 62 Demonstrates Positive 62 Pulse Oximeters 62 Clinical Efficacy 62 Liprotamase 62 Successfully Completes Phase 62 Hematological 62 Uterine Fibroid Embolization 62 Aortic Aneurysm 62 Spinal Manipulation 62 REMINDER ORLive Presents 62 Biphasic 62 Breast Cancer Treatment 62 Myelofibrosis 62 Inhaled Nitric Oxide 62 Knee Osteoarthritis 62 Lupus Nephritis 62 toenail onychomycosis 62 Peripheral Artery Disease 62 Neuromuscular Disorders 62 Hormone Refractory Prostate Cancer 62 Lung Cancer Drug 62 Molecular Diagnostic Test 62 Demonstrates Efficacy 62 Myocardial Perfusion Imaging 62 Prostate Cancer Patients 61 Neuropathic Pain 61 Improve Outcomes 61 Colorectal Screening 61 Gastrointestinal Stromal Tumors 61 Mitral Valve Repair 61 Adjuvant Chemotherapy 61 Bare Metal Stent 61 Less Invasive 61 Insulin Resistance 61 Pivotal Study 61 Postmenopausal Osteoporosis 61 Adjunctive Therapy 61 Acute Renal Failure 61 External Defibrillators 61 Neurosurgical Products 61 Improved Outcomes 61 Prostate Cancer Vaccine 61 Bazedoxifene 61 Dendritic Cells 61 Molecular Basis 61 Gynecologic 61 Oral Presentations 61 Demonstrates Potential 61 Skin Lesions 61 Platelet Inhibition 61 Drug Eluting Stents 61 Antiviral Therapy 61 Left Ventricular Dysfunction 61 Obese Patients 61 Systemic Lupus Erythematosus SLE 61 Molecular Mechanism 61 Surgical Mesh 61 Osteoporosis Drug 61 Pemphigus 61 Novel Treatments 61 pacemakers implantable cardioverter defibrillatorsHELB 61 Antipsychotic 61 FDA Clears 61 siRNA Delivery 61 Minimally Invasive Procedure 61 Enzyme Replacement Therapy 61 essential thrombocythemia ET 61 Hormonal Contraceptives 61 SUTENT ® 61 Non Invasive 61 Treatment Reduces 61 Study Validates 61 Protein Expression 61 J Nutr 61 Pediatric Cardiac 61 Stakeholder Opinions 61 Nonclinical 61 Phase III Trial 61 Anticancer Agent 61 Hedgehog Pathway Inhibitor 61 Renal Cell Carcinoma 61 Investigator Initiated 61 Demonstrate Significant 61 Glatiramer Acetate 61 Cholesterol Lowering Drug 61 Breast Cancer Recurrence 61 CABG Surgery 61 Uterine Cancer 61 Nonalcoholic Fatty Liver Disease 61 Alternative Treatments 61 Phase IIa Clinical Trial 61 Generic Versions 61 Hematologic 61 Dry Powder Inhaler 61 Coronary Artery Calcium 61 Genes Identified 61 Cancer Biomarkers 61 Treating Depression 61 Contrast Agents 61 Treatment Algorithms 61 Genetic Markers 61 Stent Placement 61 Therapeutic Potential 61 Electrophysiology Mapping 61 Breast Ultrasound 61 Advanced Colorectal Cancer 61 Neoplasms 61 Invasive Breast Cancer 61 Metabolic Bone Disease 61 Osteoarthritis Pain 61 NAVISTAR R 61 Advanced Prostate Cancer 61 HP Acthar Gel repository 61 Cardiac Arrhythmia 61 Clinical Trial Enrollment 61 Bone Marrow Transplants 61 Genetic Variation 61 Stress Urinary Incontinence 61 Therapeutic Competitors Report 61 Long Term Efficacy 61 Post Menopausal 61 Cardio Vascular 61 PharmaVitae Profile 61 Postmenopausal Women 61 EECP R 61 Betaferon R 61 Hemostasis 61 Recurrent Breast Cancer 61 ONCOLOGY 61 Chemotherapeutic Agents 61 Periodontal Disease 61 First Patient Enrolled 61 Targeted Therapies 61 XYZAL R 61 Mycophenolate Mofetil 61 Insulin Sensitivity 61 Implantable Cardioverter Defibrillators 61 Renal Impairment 61 Localized Prostate Cancer 61 entitled Formulary Advantages 61 Percutaneous Tibial Nerve Stimulation 61 Elderly Patients 61 Dose Escalation 61 Allergy Cardiovascular 61 Myoblast 61 Decompensated Heart Failure 61 Transplant Rejection 61 Nonalcoholic Steatohepatitis 61 Sleep Disorder 61 Bladder Cancer 61 Metastatic Cancer 61 Improved Survival 61 Vascular Grafts 61 Complicated Skin 61 Receives Milestone Payment 61 Immune Cell 61 Implantable Device 61 Patient Oriented 61 GI motility disorders 61 LUMINATE 61 Progenitor Cells 61 Cognitive Deficits 61 CLINICAL PHARMACOLOGY 61 Randomized Controlled Trials 61 Gout Drug 61 Cellular Therapies 61 Cytometry 61 Migraine Headache 61 Cancer Treatments 61 Ancrod 61 Skeletal Muscle 61 Vascular Disease 61 Unapproved Drugs 61 Genes Involved 61 Pooled Analysis 61 Renal Function 61 Advanced Heart Failure 61 Therapy Improves 61 Valve Replacement 61 Single Dose 61 Randomized Clinical Trials 61 Antibody Discovery 61 Chronic Lymphocytic Leukemia 61 Tezampanel 61 Replacement Therapy 61 Leukemias 61 Rotavirus Vaccine 61 Total Knee Arthroplasty 61 Parathyroid Hormone 61 abacavir Ziagen 61 Abstract Accepted 61 Pediatric Diabetes 61 Antiplatelet Therapy 61 Circulating Tumor Cells 61 Novel Mechanism 61 Interferon Alfa 61 Immunologic 61 Oral Insulin 61 Placebo Controlled Trial 61 Soft Tissue Sarcoma 61 Adult Stem Cell Therapy 61 #:# -# [005] 61 Begins Dosing 61 Thrombotic 61 IND Application 61 Subtypes 61 Immunodeficiency 61 Randomized Clinical Trial 61 Smooth Muscle 61 Pharmacoeconomic 61 Targeted Therapy 60 Reminyl galantamine 60 Presents Preclinical 60 kidney urologic 60 Irritable Bowel 60 Antithrombotic 60 First Patient Treated 60 Parenteral Nutrition 60 Preterm Labor 60 Treatment Naïve 60 Cancer Therapies 60 Embolic Protection 60 J Clin 60 Initiates Phase II 60 Inhaled Corticosteroids 60 Oncologic 60 Lung Cancer Survival 60 Arrhythmias 60 HER2 Positive Breast Cancer 60 Cardiovascular Disease Risk 60 Antipsychotic Medications 60 Glaucoma Treatment 60 Lubiprostone 60 Neuroendocrine Tumors 60 Wound Closure Devices 60 Lymphoma Patients 60 Pulmonary Hypertension 60 Peritoneal Dialysis 60 Chronic Lymphocytic Leukemia CLL 60 Musculoskeletal Disorders 60 Therapeutic Apheresis 60 Arthritis Drug 60 Progenitor Cell 60 alfuzosin 60 Erythropoietic 60 Psychotic Disorders 60 Cardiometabolic Risk 60 Calcium Acetate 60 Contrast Agent 60 Therapy Shows Promise 60 Renal Failure 60 Anticancer Agents 60 Aztreonam Lysine 60 Valopicitabine 60 Companion Diagnostics 60 Coronary Revascularization 60 Autologous Stem Cell Transplantation 60 Depressive Symptoms 60 Announces FDA Clearance 60 Coronary Artery Bypass Graft 60 Thoracic Surgeon 60 Hormone Therapy 60 cardio renal 60 FDA Okays 60 Injectable Drug 60 #:#-#,# [003] 60 Catheter Ablation 60 Pediatric Patients 60 Nucleic Acids 60 Islet Transplantation 60 Significantly Improves 60 Ischaemic 60 Early Diagnosis 60 INSPIRE Trial Phase III 60 Pandemic Influenza Vaccines 60 Extracorporeal Shock Wave 60 Vascular Ultrasound 60 THALOMID 60 CyberKnife Radiosurgery 60 Epilepsy Drug 60 HeFH 60 Tiotropium 60 Brain Metastases 60 Breast Density 60 Paroxysmal 60 Eluting Coronary Stent System 60 Radiopharmaceutical 60 Fecal Incontinence 60 BiTE Antibody 60 Spinal Implant 60 Acute Treatment 60 Proprietary Products 60 Nilotinib 60 Renal Cell Cancer 60 Chronic Myeloid Leukemia 60 Diabetic Nephropathy 60 Personalized Immunotherapy 60 Antiepileptic Drug 60 Extracellular Matrix 60 Peripheral Vascular Disease 60 Trodusquemine MSI 60 Pharmacogenetic 60 Cardiomyocytes 60 Neurostimulation 60 Crit Rev 60 Vascular Targeting Agents 60 Systemic Delivery 60 Genetic Screening 60 AVAPRO 60 FOLOTYN ® 60 HepaLife TM 60 Benign Prostatic Hyperplasia 60 Patient Recruitment 60 Treatment Shows Promise 60 Study Showed 60 Disease Modifying 60 Showed Significant 60 Treatment Approaches 60 Minimally Invasive Surgical 60 Drug Eluting 60 Cataract Surgery 60 Arch Neurol 60 J Am Coll 60 Myeloma Patients 60 Gene Linked 60 Small Molecule 60 Aortic Valve Replacement 60 Efficacious 60 Estrogen Therapy 60 Pharmacogenomic 60 C1 Inhibitor 60 Metastatic Prostate Cancer 60 Organ Rejection 60 Romiplostim 60 Tissue Repair 60 IL# PE#QQR 60 Cardiovascular Imaging 60 Slows Progression 60 Diabetic Retinopathy 60 Solid Tumor 60 Pivotal Trials 60 Adenoma 60 EHR Adoption 60 Poster Presentations 60 Epidemiological Studies Unit 60 Proves Effective 60 Pneumococcal Vaccine 60 Kinase Inhibitor 60 Bronchiectasis 60 Phase III Pivotal 60 Chronic Lung 60 Monoclonal Antibody 60 Pegloticase 60 Anti CD# Antibody 60 Pivotal Phase III 60 evaluating mipomersen 60 Resistant Hypertension 60 Zorbtive TM 60 Adjuvant Breast Cancer 60 Adverse Outcomes 60 MOVIPREP R 60 Coronary Angiography 60 Often Misdiagnosed 60 Sustained Reduction 60 Heart Defects 60 Current Controlled Trials 60 Collaborators Present 60 Therapeutic Competitors Companies 60 Novel Inhibitor 60 Toxicogenomics 60 Invasive Fungal Infections 60 Files Investigational 60 Pediatric Asthma 60 Anemia Drug 60 Sinus Infections 60 Retinal Vein Occlusion 60 Renal Cell Carcinoma RCC 60 MEK Inhibitor 60 Childhood Asthma 60 Whole Genome Sequencing 60 Personalized Oncology 60 Vaccine Immunology 60 Acute Myocardial Infarction 60 Reports Preclinical Data 60 Tissue Engineered 60 Bronchopulmonary Dysplasia 60 Menopausal Symptoms 60 Premature Infants 60 Outpatient Setting 60 Computed Tomographic 60 PROCRIT R 60 #:#-# [024] 60 Synthetic Peptide 60 Ranolazine 60 Neurotherapeutics 60 Anti Inflammatory 60 GW# [003] 60 Antibody Therapeutics 60 Study Evaluating 60 Pipeline Analysis 60 Immunosuppressive 60 Newly Diagnosed Breast Cancer 60 Plaque Psoriasis 60 Stem Cell Treatment 60 categories Glucose Monitoring 60 Phase 2b Study 60 Central Venous Catheters 60 Molecular Pathogenesis 60 Functional Outcomes 60 Cardiac Stem Cell 60 Reduced Risk 60 Antithrombin 60 Serdolect ® 60 Trandolapril 60 Pertuzumab 60 Randomized Study 60 #:#-# [033] 60 Bucindolol 60 Cognitive Disorders 60 endocrinology gastroenterology 60 Patient Focused 60 Pulmonary Arterial Hypertension PAH 60 Glycemic Control 60 Hsp# Inhibitor 60 Arterial Hypertension 60 Levels Linked 60 AVONEX ® 60 Hyperparathyroidism 60 Anticoagulant 60 Treatment Naive Patients 60 Helps Predict 60 Aortic Valve 60 VIVITROL ® 60 Clin J 60 Psychiatric Illness 60 Interventional Cardiologists 60 NDA Submission 60 Airway Inflammation 60 Iron Deficiency 60 Paroxysmal Nocturnal Hemoglobinuria PNH 60 Pemphigus Vulgaris 60 Long Term Survival 60 Zeldox 60 Clinical 60 MR Angiography 60 Dry Powder Inhalers 60 Systemic Therapy 60 Anticoagulants 60 Preclinical Studies 60 FDA Accepts 59 Sexual Function 59 Intravenous Immunoglobulin 59 Diabetes Obesity 59 Test Detects 59 Unstable Angina 59 Influenza Vaccine 59 Antipsychotic Drug 59 Clinical Documentation 59 Pelvic Floor 59 Pulse Oximetry 59 Dyloject TM 59 Screening Mammography 59 Brain Plasticity 59 Critical Limb Ischemia CLI 59 Antifungal 59 Newly Diagnosed 59 dual endothelin receptor antagonist 59 Aggressive Reduction 59 Cellular Immunotherapy 59 Oral Anticoagulants 59 lexidronam injection 59 Prognostic Factors 59 NICE Recommends 59 Phase III Trials 59 Mimetics 59 Hepatotoxicity 59 dyslipidemia hypertension diabetes 59 Erythropoiesis Stimulating Agents ESAs 59 Key Attributes 59 Hip Fractures 59 Prehospital 59 Clinical Validation 59 Preclinical Study 59 IMiDs ® compound 59 TNF Blockers 59 Monoclonal Antibodies 59 Chronic Pelvic Pain 59 Study Raises Questions 59 Childhood Immunizations 59 Teriparatide 59 Insulin Therapy 59 Wellstat 59 Protein Linked 59 Potent Antiviral Activity 59 Ophthalmic Surgery 59 Colorectal Cancers 59 Low Incidence 59 Clinical Trials Review 59 Acute Coronary Syndromes ACS 59 Human Neural Stem 59 Venous Thrombosis 59 Short Stature 59 FSCAI 59 Lower Extremity 59 Blood Pressure Monitoring 59 Cell Lymphoma 59 Heart Failure Therapy 59 Biopharmaceutical Manufacturing 59 Antiviral Agents 59 Immunotherapies 59 M.D. Ph.D. 59 Previously Treated 59 ACE Inhibitor 59 Payer Forum 59 Ventricular Assist Devices 59 Glucose Monitoring 59 Hormone Replacement 59 Endovascular Treatment 59 Reimbursement Issues 59 Treated Patients 59 MassGeneral Institute 59 Cervical Spine 59 Blood Glucose Testing 59 Systolic Hypertension 59 Migraine Drug 59 Nosocomial 59 Myelodysplastic Syndrome MDS 59 VNS Therapy TM 59 Ridaforolimus 59 Unresectable 59 Molecular Biomarkers 59 Microwave Ablation System 59 Ebola Vaccine 59 Rheumatoid 59 Blood Cancers 59 Cardiac Pacing 59 Novel Small Molecule 59 Atrial Fibrillation Treatment 59 Surgical Outcomes 59 Gastrointestinal Disease 59 Reflux Disease 59 Pediatric Psychopharmacology 59 Adverse Reactions 59 Immunomodulatory 59 Brain Stimulation 59 Raptiva R 59 STELARA TM 59 Antiangiogenic 59 Demonstrates Statistically Significant 59 Intravitreal 59 Relapsing Remitting Multiple Sclerosis 59 Anti Tumor Activity 59 Stem Cell Transplant 59 Aliskiren 59 Recombinant Human 59 Coronary Arteries 59 Gastrointestinal Liner 59 drugs davunetide intranasal 59 Novel Antibody 59 Observational Study 59 Vascular Imaging 59 Myelodysplastic Syndrome 59 Aortic Stenosis 59 Drug Eluting Coronary Stent 59 Placebo Controlled Study 59 Shows Promising 59 Sapacitabine 59 HuMax 59 Physician Insights 59 Pelvic Surgery 59 Poorly Controlled 59 Virus Infection 59 Idiopathic Pulmonary Fibrosis 59 Vascular Dementia 59 Seasonal Influenza 59 Therapeutic Targets 59 Chronic Constipation 59 Confirms Efficacy 59 #:# -# [003] 59 CYT# potent vascular disrupting 59 Oral Calcitonin 59 Microvascular 59 DNAwithPap TM Test 59 Endovascular System 59 Intracerebral Hemorrhage 59 Metastatic Renal Cell Carcinoma 59 transthyretin TTR mediated amyloidosis 59 Resubmission 59 Individualized Treatment 59 Biochemical Genetics 59 Neurologic Disorders 59 Interferon Beta 59 Cardio vascular 59 Panic Disorder 59 Vitrasert R 59 Insulin Pumps 59 Faropenem 59 Phase IIb Trial 59 Electroencephalography 59 Decitabine 59 Iron Deficiency Anemia 59 Digital Pathology 59 Immunosuppressant 59 Endometrial Cancer 59 Motility 59 Interstitial Cystitis 59 Trauma Fixation 59 Is Well Tolerated 59 Appears Safe 59 Weight Reduction 59 Respiratory Distress 59 Hemodynamics 59 Therapeutic Vaccine 59 Thalomid ® 59 Cholesterol Levels SPARCL 59 Catheter Associated 59 CNS Disorders 59 Pharmaceuticals Initiates 59 Acne Drug 59 Hepatic Encephalopathy 59 Anti Inflammatory Drugs 59 Cardiovasc 59 Gamunex C 59 Advanced Pancreatic Cancer 59 mechanical thrombectomy